POST Online Media Lite Edition



 

Mexico to conduct trials for China, U.S. coronavirus vaccines, eyes production

Christian Fernsby |
Mexico aims to conduct late stage clinical trials for coronavirus vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday.

Article continues below



Topics: MEXICO    CHINA    U.S.    VACCINES   

Mexico has signed memorandums of understanding with Johnson and Johnson, along with Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at news conference.

Ebrard said the trials would start between September and January, depending on approval from Mexico’s food and drug agency.

He said the goal to secure access to the drugs for Mexico, highlighting growing anxiety and “vaccine diplomacy” around the world as developing countries jostle to get timely access to treatments and vaccines.

“This is what worries President (Andres Manuel) Lopez Obrador, that we have it on time,” Ebrard said. The foreign ministry said CanSino and Walvax were interested in producing an eventual vaccine in Mexico for delivery to the Latin American market.


What to read next

EU and Mexico reach new agreement, all trade will be duty-free
Canada announces major steps in treating and preventing coronavirus
EU lawmakers adopt regulation to allow coronavirus vaccines developed more quickly